IRhythm Technologies Research and Development Expenses 2015-2024 | IRTC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

IRhythm Technologies research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

IRhythm Technologies Research and Development Expenses 2015-2024 | IRTC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

IRhythm Technologies research and development expenses from 2015 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$9.2B
Inspire Medical Systems (INSP)	$5.7B
Hims & Hers Health (HIMS)	$5.5B
Enovis (ENOV)	$2.6B
Privia Health (PRVA)	$2.6B
Azenta (AZTA)	$2.2B
Omnicell (OMCL)	$2.1B
10x Genomics (TXG)	$1.7B
Clover Health Investments (CLOV)	$1.7B
Schrodinger (SDGR)	$1.5B
Phreesia (PHR)	$1.1B
Butterfly Network (BFLY)	$690M
Standard BioTools (LAB)	$596M
Talkspace (TALK)	$583M
Fulgent Genetics (FLGT)	$547M
Definitive Healthcare (DH)	$505M
Health Catalyst (HCAT)	$495M
Pulmonx (LUNG)	$268M
TruBridge (TBRG)	$247M
SOPHiA GENETICS SA (SOPH)	$209M
American Well (AMWL)	$124M
EUDA Health Holdings (EUDA)	$112M
P3 Health Partners (PIII)	$76M
HeartBeam (BEAT)	$74M
111 (YI)	$52M
CareCloud (CCLD)	$46M
Outset Medical (OM)	$44M
SHL Telemedicine (SHLT)	$42M
Zepp Health (ZEPP)	$37M
Movano (MOVE)	$23M